Cases & Deals

Nephron targets better health care using smart contracts

Clients Nephron Pharmaceuticals Corporation

Jones Day is providing intellectual property advice to Nephron Pharmaceuticals Corporation's blockchain venture that seeks to track outpatient compliance using next generation handheld drug delivery devices and digital ledger infrastructure. The technology will provide a connected ecosystem and chain of data provenance between manufacturers, hospitals, health care providers, auditors, and regulators.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.